Cabasag, Carlyle Ruby Y.

HRN: 21-58-27  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/28/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/28/2026
06/04/2026
IV
800mg
Q6
Acute Tonsillopharyngitis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Eye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: Compliant To Guidelines